| Q0249 | Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg |
| G9515 | Patient did not require a return to the operating room within 90 days of surgery |
| G9305 | Intervention for presence of leak of endoluminal contents through an anastomosis not required |
| G9306 | Intervention for presence of leak of endoluminal contents through an anastomosis required |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required |
| G8569 | Prolonged postoperative intubation (> 24 hrs) required |
| G8570 | Prolonged postoperative intubation (> 24 hrs) not required |
| G8576 | No postoperative renal failure/dialysis not required |
